New Tool: ProSource
Check out our packaging and processing solutions finder, ProSource.

New Stem Cell Therapy Shows Promise for Heart Failure Patients

The transplanted cells do not trigger tumor formation, a common complication associated with stem cell therapies.

Prof Karl Tryggvason & Dr Lynn Yap
Prof Karl Tryggvason & Dr. Lynn Yap

According to a recent SciTechDaily article, researchers at Duke-NUS Medical School have developed a stem cell therapy for heart failure that showed great potential in preclinical trials. The therapy involves using pluripotent stem cells grown in the lab to repair damaged heart tissue and improve heart function when transplanted into a damaged heart. The innovative procedure could transform the treatment of heart failure by reducing complications such as arrhythmias and promoting the regeneration of healthy heart tissue. The study showed that transplanted stem cells were rapidly accepted by the body, resulting in the growth of new heart tissue and an increase in functional development, suggesting the protocol could be an effective and safe means for cell therapy.

The researchers believe this technology brings them closer to offering a new treatment for heart failure patients and has the potential to revolutionize regenerative cardiology by providing a reliable protocol to restore damaged heart muscles while reducing adverse side effects.

How to Honor a Leader
Induction into the Packaging & Processing Hall of Fame is the highest honor in our industry. Submit your leader to be considered for the Class of 2024 now through June 10th. New members will be inducted at PACK EXPO International in Chicago.
Read More
How to Honor a Leader
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts